[VALENCIALEAKS] – Ransomware Victim: duopharmabiotech[.]com
Ransomware Group: VALENCIALEAKS
VICTIM NAME: duopharmabiotech[.]com
NOTE: No files or stolen information are [exfiltrated/downloaded/taken/hosted/seen/reposted/disclosed] by RedPacket Security. Any legal issues relating to the content of the files should be directed at the attackers directly, not RedPacket Security. This blog is simply posting an editorial news post informing that a company has fallen victim to a ransomware attack. RedPacket Security is in no way affiliated or aligned with any ransomware threat actors or groups and will not host infringing content. The information on this page is fully automated and redacted whilst being scraped directly from the VALENCIALEAKS Onion Dark Web Tor Blog page.
Summary of the Ransomware Leak Page
The ransomware leak page associated with the victim identified as duopharmabiotech.com was posted by the group known as ValenciaLeaks. The discovered date of the leak is September 18, 2024, with the data extraction reportedly taking place on August 23, 2024. The leak includes significant data, amounting to 25.7GB.
The information indicates that third-party entities were involved, with 9 third-party users and domains mentioned. While the page details the activities related to the healthcare industry, specific identities of the individuals or entities involved have been sanitized and are not disclosed. The leak page includes a screenshot providing a visual representation of the contents revealed by the ransomware group.
- Victim Name: duopharmabiotech.com
- Industry: Healthcare
- Country: Malaysia (MY)
- Data Leak Amount: 25.7GB
- Leaks published on: September 18, 2024
A considerable amount of time and effort goes into maintaining this website, creating backend automation and creating new features and content for you to make actionable intelligence decisions. Everyone that supports the site helps enable new functionality.
If you like the site, please support us on “Patreon” or “Buy Me A Coffee” using the buttons below
To keep up to date follow us on the below channels.
